Brainsway Deep TMS Therapy - for Brain Disorder Treatment

About Brainsway Deep TMS Therapy - Patients

Brainsway – A New Dawn in Brain Disorder Treatment

Brainsway* has introduced a new era in brain disorder treatment, with a safe, effective* drug-free TMS therapy which can help patients to leave the hardships caused by brain disorders behind. Brainsway's Deep TMS treatment (Deep Transcranial Magnetic Stimulation) is a well-tolerated treatment which can stimulate the brain regions responsible for various types of brain disorders and bring significant improvement to patients.

A non-invasive outpatient procedure, Brainsway Deep TMS therapy does not require hospitalization or anesthesia, and entails no memory loss, no systemic side effects* or an indefinite drug regime.

Effective for a Wide Range of Brain Disorders

Brainsway Deep TMS therapy has been proven to be effective* for the following conditions:

  • Alzheimer's disease
  • Autism
  • Bipolar disorder
  • Chronic pain
  • Major depressive disorder
  • Parkinson's disease
  • Posttraumatic stress disorder (PTSD)
  • Schizophrenia (negative symptoms)
  • Smoking cessation
  • OCD
  • Stroke rehabilitation
  • Multiple Sclerosis

Brainsway's advantages over other treatments for depression – click here to learn more.

Brainsway technology video - click here to view.

Brief Short-Term TMS Therapy

Brainsway Deep TMS sessions provide effective results in nearly half the time of other TMS treatments (just 20 minutes compared to 37 with traditional TMS).  Brainsway's Deep TMS Therapy requires only brief daily sessions of 20 minutes over 4-6 weeks. In each session, the patient is comfortably seated in a chair, and a cushioned helmet is gently placed over the head. The helmet generates brief magnetic fields, similar to those used in magnetic resonance imaging (MRI) systems. After each session, patients can return home independently, and immediately resume their daily routine. 

For references click here

For safety information click here

The Brainsway Deep TMS Therapy is indicated by the FDA for the treatment of depressive episodes in adult patients suffering from Major Depressive Disorder, who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode. FDA 510(k) No. K122288

© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use